Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class A common stock, par value $0.0001 per share
-
Shares outstanding
-
1.26M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
27.7K
-
Shares change
-
+27.1K
-
Total reported value, excl. options
-
$281K
-
Value change
-
+$275K
-
Number of buys
-
1
-
Price
-
$10.17
Significant Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q4 2023
1 filings reported holding DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share as of Q4 2023.
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.7K shares
of 1.26M outstanding shares and own 2.19% of the company stock.
Largest 10 shareholders include Calamos Advisors LLC (350K shares), GLAZER CAPITAL, LLC (311K shares), KIM, LLC (247K shares), BERKLEY W R CORP (225K shares), Westchester Capital Management, LLC (225K shares), Cohanzick Management, LLC (190K shares), Centiva Capital, LP (188K shares), AQR Arbitrage LLC (162K shares), Karpus Management, Inc. (137K shares), and PERISCOPE CAPITAL INC. (125K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.